Inflammatory bowel disease [IBD] has a multifactorial origin and originates from a complex
interplay of environmental factors with the innate immune system at the intestinal epithelial …

Crohn's disease and ulcerative colitis, known together as inflammatory bowel disease (IBD),
are severe autoimmune disorders now causing gut inflammation and ulceration, among …

Inflammatory bowel disease (IBD) is an immune-mediated disease of the intestinal tract, with
complex pathophysiology involving genetic, environmental, microbiome, immunological and …

The inflammatory bowel disease (IBD) is a systemic disease that is characterized by the
inflammation of the gastrointestinal tract. It includes ulcerative colitis and the Crohn's …

Background Inflammatory bowel disease (IBD) is a chronic complex disease of the
gastrointestinal tract. Patients with IBD can experience a wide range of symptoms, but the …

Omics technology presents an exciting and timely opportunity to improve our understanding
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …

Recent genome-wide genetic association studies and advances in molecular analysis of
microbial composition have improved dramatically our understanding of the pathogenesis of …

Inflammatory bowel disease (IBD) is presently one of the most investigated human
disorders. Expansion of knowledge of its pathophysiology has helped in developing novel …

Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative
colitis (UC), are complex and heterogeneous diseases characterized by a multifactorial …

Inflammatory bowel disease (IBD) is characterized by complex etiology and a disrupted
colonic ecosystem. We provide a framework for the analysis of multi-omic data, which we …